Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A BAZEMORE

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Journal of Breath Research|January 12, 2012
Biomedically important pathogenic fungi detection with volatile biomarkersR A Bazemore, Jason Feng, Leland Cseke, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 1, 1996
Repeat-dose toxicity and pharmacokinetics of a partial phosphorothioate anti-HIV oligonucleotide (AR177) after bolus intravenous administration to cynomolgus monkeysT L Wallace, S A Bazemore, D J Kornbrust, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 1, 1996
Single-dose hemodynamic toxicity and pharmacokinetics of a partial phosphorothioate anti-HIV oligonucleotide (AR177) after intravenous infusion to cynomolgus monkeysT L Wallace, S A Bazemore, D J Kornbrust, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1997
Pharmacokinetics and distribution of a 33P-labeled anti-human immunodeficiency virus oligonucleotide (AR177) after single- and multiple-dose intravenous administration to ratsT L Wallace, S A Bazemore, K Holm, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Journal of Breath Research|January 12, 2012
Biomedically important pathogenic fungi detection with volatile biomarkersR A Bazemore, Jason Feng, Leland Cseke, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 1, 1996
Repeat-dose toxicity and pharmacokinetics of a partial phosphorothioate anti-HIV oligonucleotide (AR177) after bolus intravenous administration to cynomolgus monkeysT L Wallace, S A Bazemore, D J Kornbrust, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 1, 1996
Single-dose hemodynamic toxicity and pharmacokinetics of a partial phosphorothioate anti-HIV oligonucleotide (AR177) after intravenous infusion to cynomolgus monkeysT L Wallace, S A Bazemore, D J Kornbrust, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1997
Pharmacokinetics and distribution of a 33P-labeled anti-human immunodeficiency virus oligonucleotide (AR177) after single- and multiple-dose intravenous administration to ratsT L Wallace, S A Bazemore, K Holm, et al.
Pageof 1